ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 312 filers reported holding ROYALTY PHARMA PLC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,161,000 | -20.3% | 153,298 | -9.7% | 0.02% | -9.5% |
| Q2 2023 | $5,219,000 | -23.5% | 169,782 | -10.3% | 0.02% | -25.0% |
| Q1 2023 | $6,821,000 | -11.2% | 189,320 | -2.5% | 0.03% | -15.2% |
| Q4 2022 | $7,677,000 | +0.8% | 194,268 | +2.5% | 0.03% | -2.9% |
| Q3 2022 | $7,618,000 | -2.4% | 189,596 | +2.1% | 0.03% | +3.0% |
| Q2 2022 | $7,808,000 | -15.1% | 185,727 | -21.3% | 0.03% | +3.1% |
| Q1 2022 | $9,200,000 | +31.2% | 236,141 | +34.2% | 0.03% | +33.3% |
| Q4 2021 | $7,011,000 | +6.4% | 175,939 | -3.5% | 0.02% | +4.3% |
| Q3 2021 | $6,588,000 | -13.6% | 182,299 | -2.0% | 0.02% | -14.8% |
| Q2 2021 | $7,627,000 | +1.7% | 186,071 | +8.3% | 0.03% | -10.0% |
| Q1 2021 | $7,496,000 | +180.1% | 171,839 | +221.4% | 0.03% | +150.0% |
| Q4 2020 | $2,676,000 | – | 53,466 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |